Anavex Life Sciences Corp (AVXL)

[TTTav66]

Anavex's SVP of Operations, Stephan Toutain, to speak at the World BI - 13th Clinical Trials Conference, May 7-8 in Boston, MA.
https://worldbigroup.com/conference/thirteenth-clinical-trials/speakers

As a reminder, known event participation going into the summer:

May 7-8: World BI - 13th Clinical Trials Conference - Boston, MA
Speaker: Stephan Toutain
https://worldbigroup.com/conference/thirteenth-clinical-trials/speakers


June 3-6 : Bio International Convention - Philadelphia, PA
Anavex currently indicated as attending and participating in 1-on-1 Partnering sessions.
https://mybio.org/exhibitor/member/318490


June 25 : DIA 2019 Global Annual Meeting - San Diego, CA
Artificial Intelligence Enhanced Data Analytics for Clinical Trials
Panelists: Mohammad Afshar (CEO of Ariana Pharma), and Federico Goodsaid (Principal of Regulatory Pathfinders)
*note: Indication of Dr. Missling's participation was removed at some point after this event was originally shared
https://dia2019globalannualmeeting.sched.com/event/KfWl/245-artificial-intelligence-enhanced-data-analytics-for-clinical-trials


July 23-25 : 2nd Annual NPP (Neuropsychiatric Drug Development) Conference - Boston, MA
- Dr. Missling will lead a workshop; Reviewing the Potential for Precision Medicine in Neurological Diseases on July 23.
- He will also be featured in a 2 person panel with the Executive Director of Neuroscience Discovery at Merck; Panel Discussion: The Precision Medicine Approach to Neuropsychiatry – For or Against? on July 25.
https://npd-summit.com/